TY - JOUR
T1 - Immunohistochemistry in the Diagnosis and Classification of Breast Tumors
AU - Sun, Hongxia
AU - Ding, Qingqing
AU - Sahin, Aysegul A.
N1 - Publisher Copyright:
© 2023 College of American Pathologists. All rights reserved.
PY - 2023/10
Y1 - 2023/10
N2 - Context.-In the clinical practice of breast pathology, immunohistochemistry (IHC) of different markers is widely used for the diagnosis and classification of breast lesions. Objective.-To provide an overview of currently used and recently identified IHC stains that have been implemented in the field of diagnostic breast pathology. Data Sources.-Data were obtained from literature review and clinical experience of the authors as breast pathologists. Conclusions.-In the current review, we summarize the common uses of IHC stains for diagnosing different types of breast lesions, especially invasive and noninvasive breast lesions, and benign and malignant spindle cell lesions. In addition, the cutting-edge knowledge of diagnostic carcinoma markers will lead us to further understand the different types of breast carcinoma and differentiate breast carcinomas from other carcinomas of similar morphology. Knowing the strengths and limitations of these markers is essential to the clinical practice of breast pathology.
AB - Context.-In the clinical practice of breast pathology, immunohistochemistry (IHC) of different markers is widely used for the diagnosis and classification of breast lesions. Objective.-To provide an overview of currently used and recently identified IHC stains that have been implemented in the field of diagnostic breast pathology. Data Sources.-Data were obtained from literature review and clinical experience of the authors as breast pathologists. Conclusions.-In the current review, we summarize the common uses of IHC stains for diagnosing different types of breast lesions, especially invasive and noninvasive breast lesions, and benign and malignant spindle cell lesions. In addition, the cutting-edge knowledge of diagnostic carcinoma markers will lead us to further understand the different types of breast carcinoma and differentiate breast carcinomas from other carcinomas of similar morphology. Knowing the strengths and limitations of these markers is essential to the clinical practice of breast pathology.
UR - http://www.scopus.com/inward/record.url?scp=85174967244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85174967244&partnerID=8YFLogxK
U2 - 10.5858/ARPA.2022-0464-RA
DO - 10.5858/ARPA.2022-0464-RA
M3 - Article
AN - SCOPUS:85174967244
SN - 0003-9985
VL - 147
SP - 1119
EP - 1132
JO - Archives of Pathology and Laboratory Medicine
JF - Archives of Pathology and Laboratory Medicine
IS - 10
ER -